During Michaelmas Term, OxTalks will be moving to a new platform (full details are available on the Staff Gateway).
For now, continue using the current page and event submission process (freeze period dates to be advised).
If you have any questions, please contact halo@digital.ox.ac.uk
The first FDA-approved gene therapy, Kymriah, was released to the public in August 2017 with a $475,000 price tag. With the emergence of personalized genetic medicine, we are entering a new era of profound inequality. This talk explores the stories of children and parents who signed up for the Kymriah clinical trial before it was approved—risking their lives and household finances in pursuit of a cancer cure. Issues of race and class played out at Penn Medicine, as researchers explored new horizons of hope with living cellular therapies.